Codexis, Inc.

Chemicals & Gases

50 Pharma Companies Worldwide Now Use Codexis In Process Development

Codexis Manufacturing Network Supports Pharma Customers from Development to Commercial Production FRANKFURT, Germany - Codexis, Inc. (Nasdaq: CDXS) today announced that one year after launch, its Codex® Screening Kits are in use or evaluation in manufacturing process development at 50 pharmaceutical companies worldwide. The announcement was made at CPhI Worldwide, a global pharmaceutical...

Read More »
Laboratory and Research Supplies and Equipment

Codexis, Raizen to Develop First Generation Ethanol

REDWOOD CITY, Calif. and SAO PAULO - Codexis, Inc. (Nasdaq: CDXS) and Raizen Energia S.A. today announced the signing of a joint development agreement to develop an improved first generation ethanol process with enhanced performance economics. Raizen is Brazil's largest sugar and ethanol producer. Under the terms of the agreement, Raizen and Codexis will deploy the Codexis CodeEvolver(TM)...

Read More »
Cleaning Products & Equipment

Codexis Presents Carbon Capture Update at DoE/NETL Conference

Two Million Fold Improvement in Enzyme Performance REDWOOD CITY, Calif. - Codexis, Inc. (Nasdaq: CDXS) presented important technical progress in its carbon capture program yesterday at the CO2 Capture Technology Meeting being sponsored this week by the U.S. Department of Energy/National Energy Technology Laboratory in Pittsburgh. Codexis, supported by a grant from the DoE's ARPA-E Recovery Act...

Read More »
Cleaning Products & Equipment

Codexis Announces First Cellulase Enzyme Scale up

REDWOOD CITY, Calif. - Codexis, Inc. (Nasdaq: CDXS) today announced the first scale up manufacturing of the company's proprietary cellulase enzymes at commercial scale. These enzymes are used to convert non-food biomass to fermentable sugars, and ultimately to sustainable products including biofuels and bio-based performance ingredients in household goods such as laundry detergents and shampoos....

Read More »
Cleaning Products & Equipment

Codexis Expands Codex® Panel Product Family at CPhI

Introduces Codex® Screening Kits REDWOOD CITY, Calif., Oct. 4 - Codexis, Inc. (Nasdaq: CDXS) today announced the expansion of its line of Codex® Panels with the introduction of Codex® Screening Kits. The Codex® Screening Kits are developed from, and complement, the established Codex® Panels biocatalyst screening plates. Codex® Panels are used by more than 15...

Read More »

Research Tool facilitates safe drug development.

With Codex(TM) MicroCyp Plate, pharmaceutical companies can rapidly identify and synthesize drug metabolites and novel drug lead candidates. Research tool is based on specific cytochrome enzyme, 102A1, which metabolizes fatty acids in microbe. Launch of product expands research product family, adding metabolite screening and synthesis as well as lead diversification to full suite of tools for...

Read More »
Chemicals & Gases

Biocatalyst Panels target phamaceutical industry.

Codex(TM) Biocatalyst Panels include Acylases for producing chiral amines or alcohols via resolution of amides or esters; ERED for alpha and/or beta chiral ketones, esters, and nitriles; TA for chiral amines; and HHDH for chiral halohydrins, cyanohydrins, amino alcohols, epoxides, and diols. Sets of enzyme panels are provided in 96-well format to determine if biocatalytic solution is available...

Read More »
Laboratory and Research Supplies and Equipment

Enzyme Panels facilitate biocatalyst development.

Codex(TM) Biocatalyst Panels are sets of diagnostic enzyme panels designed to screen for reactivity in desired process reactions. They enable pharmaceutical researchers to identify optimizable biocatalytic process solutions for multiple drug candidates across their pipelines. This promotes development of efficient and environmentally sound manufacturing processes prior to Phase III clinical...

Read More »
Chemicals & Gases

50 Pharma Companies Worldwide Now Use Codexis In Process Development

Codexis Manufacturing Network Supports Pharma Customers from Development to Commercial Production FRANKFURT, Germany - Codexis, Inc. (Nasdaq: CDXS) today announced that one year after launch, its Codex® Screening Kits are in use or evaluation in manufacturing process development at 50 pharmaceutical companies worldwide. The announcement was made at CPhI Worldwide, a global pharmaceutical...

Read More »
Laboratory and Research Supplies and Equipment

Codexis, Raizen to Develop First Generation Ethanol

REDWOOD CITY, Calif. and SAO PAULO - Codexis, Inc. (Nasdaq: CDXS) and Raizen Energia S.A. today announced the signing of a joint development agreement to develop an improved first generation ethanol process with enhanced performance economics. Raizen is Brazil's largest sugar and ethanol producer. Under the terms of the agreement, Raizen and Codexis will deploy the Codexis CodeEvolver(TM)...

Read More »
Cleaning Products & Equipment

Codexis Presents Carbon Capture Update at DoE/NETL Conference

Two Million Fold Improvement in Enzyme Performance REDWOOD CITY, Calif. - Codexis, Inc. (Nasdaq: CDXS) presented important technical progress in its carbon capture program yesterday at the CO2 Capture Technology Meeting being sponsored this week by the U.S. Department of Energy/National Energy Technology Laboratory in Pittsburgh. Codexis, supported by a grant from the DoE's ARPA-E Recovery Act...

Read More »
Cleaning Products & Equipment

Codexis Announces First Cellulase Enzyme Scale up

REDWOOD CITY, Calif. - Codexis, Inc. (Nasdaq: CDXS) today announced the first scale up manufacturing of the company's proprietary cellulase enzymes at commercial scale. These enzymes are used to convert non-food biomass to fermentable sugars, and ultimately to sustainable products including biofuels and bio-based performance ingredients in household goods such as laundry detergents and shampoos....

Read More »
Company News

Codexis to Present at the Jefferies and Pacific Crest Conferences

REDWOOD CITY, Calif., Feb. 8, 2011 - Codexis, Inc. (Nasdaq: CDXS) today announced the company will present at the Jefferies Global Clean Technology Conference, to be held in New York, NY on February 23-24, 2011. The presentation is scheduled for February 23 at 1:00 p.m. Eastern Time. The company will also present at the Pacific Crest Clean Technology Conference, to be held in San Francisco, CA on...

Read More »
Company News

DSM and Codexis Sign Enzyme Supply Agreement

PARSIPPANY, N.J. and REDWOOD CITY, Calif., Jan. 12, 2011 - DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV, and Codexis, Inc. (Nasdaq:CDXS) today announce signing of an enzyme supply agreement. The agreement grants DSM rights to use Codexis' custom biocatalysts and services, and secures supply of Codexis enzymes for commercialization of sustainable enzyme-based...

Read More »
Company News

Codexis to Present at Piper Conference

Codexis To Present at the Piper Jaffray Clean Technology & Renewables Conference REDWOOD CITY, Calif., Dec. 20, 2010 - Codexis, Inc. (Nasdaq: CDXS) today announced the company will present at the Piper Jaffray Clean Technology & Renewables Conference, to be held in New York, NY on January 12, 2011. The presentation will be made by Robert Lawson, Senior Vice President and Chief Financial Officer,...

Read More »
Company News

Codexis to Present at Baird Conference

REDWOOD CITY, Calif., Nov. 4, 2010 -- Codexis, Inc. (Nasdaq: CDXS) today announced that the company will participate in the Baird Clean Technology Conference, Nov. 30-Dec. 1, 2010 in San Francisco, CA. Alan Shaw, Ph.D., President and Chief Executive Officer, will give a company presentation on November 30 at 4:45 pm Pacific Time. An audio webcast and replay will be available in the Investor...

Read More »
Mergers & Acquisitions

Codexis Acquires Maxygen Directed Evolution Intellectual Property Portfolio; Biofuels Payments to Maxygen End, Codexis Fields of Use Expand

REDWOOD CITY, Calif., Oct. 28 -- Codexis, Inc. (Nasdaq: CDXS) today announced that the company has acquired the directed evolution intellectual property portfolio of Maxygen, Inc. (Nasdaq: MAXY) for $20 million in cash. With this transaction, Codexis no longer has any obligations to make payments to Maxygen, including potential royalties, relating to biofuels and other energy products. The...

Read More »
Company News

Codexis to Present at the Goldman Sachs Clean Energy Conference

REDWOOD CITY, Calif., Oct. 19 - Codexis, Inc. (Nasdaq: CDXS) today announced the company will participate in the Goldman Sachs Fifth Annual Clean Energy Conference in New York, NY on November 10-11, 2010. Alan Shaw, Ph.D., President and Chief Executive Officer, will appear on a panel titled Biomass Conversion: Back from the Brink", scheduled for November 10 at 1:30 pm Eastern Time. A webcast and...

Read More »

All Topics

COVID-19 Response Suppliers COVID-19 Response:
Can Your Company Help Provide Critical Supplies?

We are using the power of our platform to aid in the mass shortage of critical supplies. If your company can help provide supplies, capabilities, or materials for products such as N-95 Masks and Tyvek SuitsPlease let us know.

COVID-19 Response Suppliers